Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Intratympanic STR001 Thermogel to Preserve Residual Hearing During Cochlear Implant Surgery
2015-002672-25Phase 2Completed
- Sponsor
- Strekin AG
- Start
- Sep 2015
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial in Hypoacusis and sensorineural hearing loss (SNHL) comparing STR001 thermogel with Placebo (2 arms). Primary endpoint: Average Pure Tone Audiometry Threshold (aPTA) at Week 6. Started Sep 2015; status: completed.
02
Drugs
STR001
03
Conditions
Hypoacusissensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on 2015-002672-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002672-25.